BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 14748488)

  • 1. Postprandial hyperglycemia.
    Richards RJ
    J La State Med Soc; 2003; 155(5):260-5. PubMed ID: 14748488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of glucagon response on postprandial hyperglycemia in men with impaired glucose tolerance and type 2 diabetes mellitus.
    Henkel E; Menschikowski M; Koehler C; Leonhardt W; Hanefeld M
    Metabolism; 2005 Sep; 54(9):1168-73. PubMed ID: 16125528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolated post-challenge hyperglycemia: concept and clinical significance.
    Adam JM; Josten D
    Acta Med Indones; 2008 Jul; 40(3):171-5. PubMed ID: 18838757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postprandial lipaemia in patients with impaired fasting glucose, impaired glucose tolerance and diabetes mellitus.
    Madhu SV; Kant S; Srivastava S; Kant R; Sharma SB; Bhadoria DP
    Diabetes Res Clin Pract; 2008 Jun; 80(3):380-5. PubMed ID: 18321605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Critical evaluation of the oral glucose tolerance test for the diagnosis of insulin resistance in patients with polycystic ovary syndrome].
    Calvar CE; Bengolea SV; Hermes R; Loyato M
    Medicina (B Aires); 2007; 67(1):1-7. PubMed ID: 17408014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparison of fasting and 2 hours postprandial blood glucose in the control of patients with type 2 diabetes].
    García Nava RE; Rodríguez Moctezuma R; Munguía Miranda C; Hernández Santiago JL; Casas de la Torre E; Martínez Bermúdez M; Cabrera Ramírez RM
    Rev Invest Clin; 2003; 55(1):26-30. PubMed ID: 12708160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treating postprandial hyperglycemia does not appear to delay progression of early type 2 diabetes: the Early Diabetes Intervention Program.
    Kirkman MS; Shankar RR; Shankar S; Shen C; Brizendine E; Baron A; McGill J
    Diabetes Care; 2006 Sep; 29(9):2095-101. PubMed ID: 16936159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical decision making: managing postprandial hyperglycemia.
    Hurel SJ; Mohan V
    J Assoc Physicians India; 2006 Nov; 54():871-6. PubMed ID: 17249256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Postprandial hyperglycemia and diabetic complications].
    Da Ros R; Assaloni R; Ceriello A
    Recenti Prog Med; 2005 Sep; 96(9):436-44. PubMed ID: 16229326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance of post-prandial blood glucose excursions in type 1 and type 2 diabetes mellitus.
    Slama G
    Int J Clin Pract Suppl; 2000 Sep; (112):9-12. PubMed ID: 11064945
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of Momordica charantia (Karolla) extracts on fasting and postprandial serum glucose levels in NIDDM patients.
    Ahmad N; Hassan MR; Halder H; Bennoor KS
    Bangladesh Med Res Counc Bull; 1999 Apr; 25(1):11-3. PubMed ID: 10758656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impairment of the NO/cGMP pathway in the fasting and postprandial state in type 1 diabetes mellitus.
    Farkas K; Jermendy G; Herold M; Ruzicska E; Sasvári M; Somogyi A
    Exp Clin Endocrinol Diabetes; 2004 May; 112(5):258-63. PubMed ID: 15146372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diagnostic pitfall. Fasting blood glucose in the normal range--but still diabetic].
    MMW Fortschr Med; 2002 Sep; 144(35-36):56. PubMed ID: 12380362
    [No Abstract]   [Full Text] [Related]  

  • 14. Defining the role of incretin mimetic therapy in the management of type 2 diabetes.
    Unger J; Nadeau DA
    J Fam Pract; 2007 Dec; 56(12 Suppl New):S4-S10. PubMed ID: 18664341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Characteristics of glycemic excursion in different subtypes of impaired glucose intolerance].
    Kang Y; Lu JM; Sun JF; Li CL; Wang XL; Zhang XQ; Lü ZH; Dou JT; Mu YM
    Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(10):669-72. PubMed ID: 19595059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of action of exenatide to reduce postprandial hyperglycemia in type 2 diabetes.
    Cervera A; Wajcberg E; Sriwijitkamol A; Fernandez M; Zuo P; Triplitt C; Musi N; DeFronzo RA; Cersosimo E
    Am J Physiol Endocrinol Metab; 2008 May; 294(5):E846-52. PubMed ID: 18334612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic fat content is a determinant of postprandial triglyceride levels in type 2 diabetes mellitus patients with normal fasting triglyceride.
    Nimitphong H; Phongkitkarun S; Rattarasarn C; Kongsooksai A; Chanprasertyothin S; Bunnag PA; Puavilai G
    Metabolism; 2008 May; 57(5):644-9. PubMed ID: 18442627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postprandial hyperglycaemia in type 2 diabetes: pathophysiological aspects, teleological notions and flags for clinical practice.
    Boutati EI; Raptis SA
    Diabetes Metab Res Rev; 2004; 20 Suppl 2():S13-23. PubMed ID: 15551342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of tissue damage in the postprandial state.
    Ceriello A
    Int J Clin Pract Suppl; 2001 Sep; (123):7-12. PubMed ID: 11594300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Criteria for previously undiagnosed diabetes and risk of mortality: 15-year follow-up of the Edinburgh Artery Study cohort.
    Wild SH; Smith FB; Lee AJ; Fowkes FG
    Diabet Med; 2005 Apr; 22(4):490-6. PubMed ID: 15787678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.